A Healthcare Partner of Choice

New Marketlink Pharmaceutical Corporation (NMPC), was borne out of the marketing and distribution expertise of Marketlink International Corporation (MIC). It is one of the leading distributors of pharmaceutical and healthcare products in the Philippines.  It supports and markets a marquee list of established multinational medical brands. Since it began operations in 2006, the Filipino-owned company has been committed to strengthen its importation, sales, marketing and distribution of its diverse line of pharmaceutical and healthcare products.

In 2008, NMPC boosted its position as a respected leader in the pharmaceutical industry by establishing Chiral Pharma Corp., a wholly-owned subsidiary. Chiral's product range consists of women's health (pre-natal vitamins, feminine wash, labor inducers, replacement therapies in menopause); cardio-metabolic (diabetic replacement supplements); general (cough & cold preparations, anti-infectives, multi-vitamins & topical dermatological products); and over-the-counter and consumer pharmaceutical products (children's vitamins for brain development). 

In 2009, NMPC established My.Health Corp. to focus on the development and marketing of consumer healthcare products starting with Hi-Smart children's multivitamins. Hi-Smart is the official partner of the Junior NBA Program in the Philippines. 

People

The people of New Marketlink, at all levels and at all times, continue to uphold and lives out the values that give the company its heart and soul. The image of the company  projected in its  day-to-day operations is an outward manifestation of an inward personality --- shaped by Filipino tradition and conduct chosen by New Marketlink to be important.

While others rely only on product quality, New Marketlink trusts and counts on its people.

New Marketlink believes in getting close and staying close to its customers by giving them what they reasonably want and need, winning customers from competitors and keeping them.

NMPC  creates  commitment to customer service at every level of its organization; focusing employees’ efforts on giving customers  excellent service.

Its management and staff have years of outstanding track record in the field of pharmaceutical marketing. New Marketlink employees proactively respond to the needs of the pharmaceutical industry by networking with various reputable medical organizations and associations on their requirements and on current pharmaceutical trends.

NMPC has manpower deployment of 151 sales personnel and managers covering more  than 15,000 physicians nationwide.

Divisionalized organization and exclusive group by volume / specialty line allow more flexibility in  handling products without any conflict and give focus on each product, providing better market share for the partner principal and comprehensive information for the medical practitioners.

Its management team is composed of veterans in the local and regional pharmaceutical industry. 

Organization

Amado T. Tadena – Chairman & CEO

Oscar J. Aragon – President

Francis Z. Gomez, MD - Chief Operating Officer

Raul Ma. F. Anonas - Chief Finance Officer, Team Leader of Pharma Shared Services

Jose P. Ancheta, Jr. – Sales & Marketing Director

Mateo Grigo S. Villenas – Corporate Planning & Business Development Director 

Joselito R. Aguas - Human Resource Management & Administration Manager

Myra B. de Asis – Accounting Manager

Mario E. Libid, Jr. - Supply Chain Manager

Principals (Current & Previous)

• Rowa Pharmaceuticals, Ltd. -  Ireland
• Novartis Vaccine (Chiron) - Italy
• Bracco Imaging - Italy
• Newport Pharmaceuticals - Costa Rica 
• Nippon Shinyaku Co., Ltd. - Japan
• Boryung Biopharmaceuticals - Korea
• Hoe Pharma - Malaysia
• Montavit - Austria
• Beaufour Ipsen Pharma - France
• Rohto - Japan
• Apoghepa - Germany
• Kedrion - Italy
• PFM - Germany
• GluStitch, Inc.
• Merck Sharp & Dohme (MSD)
• Bharat Serums And Vaccines Limited
  
• Sandoz
  

Sub-distributor: Metro Drug, Incorporated

 

 

back to top